721 related articles for article (PubMed ID: 25201738)
21. Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment.
Assanhou AG; Li W; Zhang L; Xue L; Kong L; Sun H; Mo R; Zhang C
Biomaterials; 2015 Dec; 73():284-95. PubMed ID: 26426537
[TBL] [Abstract][Full Text] [Related]
22. Mixed micelles based on a pH-sensitive prodrug and TPGS for enhancing drug efficacy against multidrug-resistant cancer cells.
Sun D; Lv X; Wang X; Yu A; Wang Y
Colloids Surf B Biointerfaces; 2017 Nov; 159():419-426. PubMed ID: 28823972
[TBL] [Abstract][Full Text] [Related]
23. Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance.
Guo Y; Chu M; Tan S; Zhao S; Liu H; Otieno BO; Yang X; Xu C; Zhang Z
Mol Pharm; 2014 Jan; 11(1):59-70. PubMed ID: 24229050
[TBL] [Abstract][Full Text] [Related]
24. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
[TBL] [Abstract][Full Text] [Related]
25. Multifunctionalized Micelles Facilitate Intracellular Doxorubicin Delivery for Reversing Multidrug Resistance of Breast Cancer.
Cao A; Ma P; Yang T; Lan Y; Yu S; Liu L; Sun Y; Liu Y
Mol Pharm; 2019 Jun; 16(6):2502-2510. PubMed ID: 30998372
[TBL] [Abstract][Full Text] [Related]
26. Active targeting co-delivery system based on pH-sensitive methoxy-poly(ethylene glycol)2K-poly(ε-caprolactone)4K-poly(glutamic acid)1K for enhanced cancer therapy.
Li N; Huang C; Luan Y; Song A; Song Y; Garg S
J Colloid Interface Sci; 2016 Jun; 472():90-8. PubMed ID: 27016914
[TBL] [Abstract][Full Text] [Related]
27. Investigation on vitamin e succinate based intelligent hyaluronic acid micelles for overcoming drug resistance and enhancing anticancer efficacy.
Hou L; Tian C; Chen D; Yuan Y; Yan Y; Huang Q; Zhang H; Zhang Z
Eur J Pharm Sci; 2019 Dec; 140():105071. PubMed ID: 31525433
[TBL] [Abstract][Full Text] [Related]
28. Overcoming multidrug resistance by intracellular drug release and inhibiting p-glycoprotein efflux in breast cancer.
Mao J; Qiu L; Ge L; Zhou J; Ji Q; Yang Y; Long M; Wang D; Teng L; Chen J
Biomed Pharmacother; 2021 Feb; 134():111108. PubMed ID: 33341670
[TBL] [Abstract][Full Text] [Related]
29. Poly(L-lactide)-vitamin E TPGS nanoparticles enhanced the cytotoxicity of doxorubicin in drug-resistant MCF-7 breast cancer cells.
Li PY; Lai PS; Hung WC; Syu WJ
Biomacromolecules; 2010 Oct; 11(10):2576-82. PubMed ID: 20722436
[TBL] [Abstract][Full Text] [Related]
30. A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance.
He Q; Gao Y; Zhang L; Zhang Z; Gao F; Ji X; Li Y; Shi J
Biomaterials; 2011 Oct; 32(30):7711-20. PubMed ID: 21816467
[TBL] [Abstract][Full Text] [Related]
31. Stimuli-responsive, dual-function prodrug encapsulated in hyaluronic acid micelles to overcome doxorubicin resistance.
Qiu L; Xu J; Ahmed KS; Zhu M; Zhang Y; Long M; Chen W; Fang W; Zhang H; Chen J
Acta Biomater; 2022 Mar; 140():686-699. PubMed ID: 34875359
[TBL] [Abstract][Full Text] [Related]
32. P-gp Inhibition and Mitochondrial Impairment by Dual-Functional Nanostructure Based on Vitamin E Derivatives To Overcome Multidrug Resistance.
Tuguntaev RG; Chen S; Eltahan AS; Mozhi A; Jin S; Zhang J; Li C; Wang PC; Liang XJ
ACS Appl Mater Interfaces; 2017 May; 9(20):16900-16912. PubMed ID: 28463476
[TBL] [Abstract][Full Text] [Related]
33. Gold nanorod-cored biodegradable micelles as a robust and remotely controllable doxorubicin release system for potent inhibition of drug-sensitive and -resistant cancer cells.
Zhong Y; Wang C; Cheng L; Meng F; Zhong Z; Liu Z
Biomacromolecules; 2013 Jul; 14(7):2411-9. PubMed ID: 23701318
[TBL] [Abstract][Full Text] [Related]
34. Decoration of pH-sensitive copolymer micelles with tumor-specific peptide for enhanced cellular uptake of doxorubicin.
Chen Q; Long M; Qiu L; Zhu M; Li Z; Qiao M; Hu H; Zhao X; Chen D
Int J Nanomedicine; 2016; 11():5415-5427. PubMed ID: 27799766
[TBL] [Abstract][Full Text] [Related]
35. Doxorubicin Encapsulated in TPGS-Modified 2D-Nanodisks Overcomes Multidrug Resistance.
Jiang T; Zhang C; Sun W; Cao X; Choi G; Choy JH; Shi X; Guo R
Chemistry; 2020 Feb; 26(11):2470-2477. PubMed ID: 31912555
[TBL] [Abstract][Full Text] [Related]
36. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
Li C; Guan X; Xue H; Wang P; Wang M; Gai X
Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
[TBL] [Abstract][Full Text] [Related]
37. pH-Responsive therapeutic solid lipid nanoparticles for reducing P-glycoprotein-mediated drug efflux of multidrug resistant cancer cells.
Chen HH; Huang WC; Chiang WH; Liu TI; Shen MY; Hsu YH; Lin SC; Chiu HC
Int J Nanomedicine; 2015; 10():5035-48. PubMed ID: 26346762
[TBL] [Abstract][Full Text] [Related]
38. Paclitaxel delivered by CD44 receptor-targeting and endosomal pH sensitive dual functionalized hyaluronic acid micelles for multidrug resistance reversion.
Liu Y; Zhou C; Wei S; Yang T; Lan Y; Cao A; Yang J; Hou Y
Colloids Surf B Biointerfaces; 2018 Oct; 170():330-340. PubMed ID: 29936386
[TBL] [Abstract][Full Text] [Related]
39. Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor.
Lee ES; Na K; Bae YH
J Control Release; 2005 Mar; 103(2):405-18. PubMed ID: 15763623
[TBL] [Abstract][Full Text] [Related]
40. An improved D-α-tocopherol-based nanocarrier for targeted delivery of doxorubicin with reversal of multidrug resistance.
Lu J; Zhao W; Liu H; Marquez R; Huang Y; Zhang Y; Li J; Xie W; Venkataramanan R; Xu L; Li S
J Control Release; 2014 Dec; 196():272-86. PubMed ID: 25456831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
